Silje Beckinger
Kiel, SH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Serum meprin α levels for the detection of systemic inflammatory response syndrome.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 24, 2026
Regulation of keratinocyte proliferation and epidermal inflammation by meprin α-mediated cleavage of dermokine.
Journal: The Journal of investigative dermatology
Published: October 02, 2025
Synergistic Effect of Anti-PD-L1 Treatment and CD8+ T-Cell Activating Nanotherapy in Pancreatic Ductal Adenocarcinoma Evaluated via 3D Mathematical Modeling.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: October 07, 2024
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells.
Journal: International journal of molecular sciences
Published: February 27, 2023
Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma.
Journal: Frontiers in oncology
Published: February 07, 2023
Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.
Journal: Frontiers in immunology
Published: February 02, 2023
Biomarkers in Liquid Biopsies for Prediction of Early Liver Metastases in Pancreatic Cancer.
Journal: Cancers
Published: July 29, 2022
Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control.
Journal: Medical sciences (Basel, Switzerland)
Published: March 24, 2021
Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses.
Journal: PloS one
Published: May 07, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026